Clinical profiles of hypertrophic cardiomyopathy with apical phenotype: Comparison of pure-apical form and distal-dominant form

Circulation Journal

Volumn 73, Issue 12, 2009, Pages 2330-2336

  Kubo, Toru ^a   Kitaoka, Hiroaki ^a   Okawa, Makoto ^a   Hirota, Takayoshi ^a   Hoshikawa, Eri ^a   Hayato, Kayo ^a   Yamasaki, Naohito ^a   Matsumura, Yoshihisa ^a   Yabe, Toshikazu ^a   Nishinaga, Masanori ^a   Takata, Jun ^a   Doi, Yoshinori L ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Apex; Hypertrophic cardiomyopathy; Phenotypes

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; GENETIC VARIABILITY; HEART LEFT ATRIUM; HEART SIZE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MITRAL ANNULOPLASTY; PHENOTYPE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CHILD; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 73349128085     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0438     Document Type: Article

References (34)

1. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-785.
2. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003; 42: 1687-1713.
3. Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002; 287: 1308-1320.
4. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet 2004; 363: 1881-1891.
5. Motoyasu M, Kurita T, Onishi K, Uemura S, Tanigawa T, Okinaka T, et al. Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by magnetic resonance imaging. Circ J 2008; 72: 378-383.
6. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle: Echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J 1976; 17: 611-629.
7. Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, et al. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979; 44: 401-412.
8. Koga Y, Katoh A, Matsuyama K, Ikeda H, Hiyamuta K, Toshima H. Disappearance of giant negative T waves in patients with the Japanese form of apical hypertrophy. J Am Coll Cardiol 1995; 26: 1672-1678.
9. Suzuki J, Watanabe F, Takenaka K, Amano K, Amano W, Igarashi T, et al. New subtype of apical hypertrophic cardiomyopathy identified with nuclear magnetic imaging as an underlying cause of markedly inverted T waves. J Am Coll Cardiol 1993; 22: 1175-1181.
10. Koga Y, Nohara M, Miyazaki Y, Toshima H. Two forms of apical hypertrophic cardiomyopathy: Japanese and Western forms. In: Toshima H, Maron BJ, editors. Cardiomyopathy updated. 2: Hypertrophic cardiomyopathy. Tokyo, Japan: University of Tokyo Press; 1988; 293-308.
11. Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 39: 638-645.
12. Kitaoka H, Doi Y, Casey SA, Hitomi N, Furuno T, Maron BJ. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol 2003; 92: 1183-1186.
13. Doi Y, Kitaoka H, Hitomi N, Yamasaki N, Matsumura Y, Furuno T, et al. Hypertrophic cardiomyopathy in Japan: Clinical, morphologic and genetic expression. In: Maron BJ, editor. Diagnosis and management of hypertrophic cardiomyopathy. Malden, MA: Blackwell/Futura; 2004; 185-194.
14. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A two-dimensional echocardiographic study. J Am Coll Cardiol 1983; 2: 437-444.
15. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418-428.
16. Nagueh SF, Lakkis NM, Middleton KJ, Spencer WH 3rd, Zoghbi WA, Quinones MA. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 1999; 99: 254-261.
17. Efthimiadis GK, Giannakoulas G, Parcharidou DG, Karvounis HI, Mochlas ST, Styliadis IH, et al. Clinical significance of tissue Doppler imaging in patients with hypertrophic cardiomyopathy. Circ J 2007; 71: 897-903.
18. Maron BJ, Bonow RO, Seshagiri TNR, Roberts WC, Epstein SE. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Am J Cardiol 1982; 49: 1838-1848.
19. Vacek JL, Davis WR, Bellinger RL, McKiernan TL. Apical hypertrophic cardiomyopathy in American patients. Am Heart J 1984; 108: 1501-1506.
20. Abinader EG, Rauchfleisch S, Naschits J. Hypertrophic apical cardiomyopathy: A subtype of hypertrophic cardiomyopathy. Israel J Med Sci 1982; 18: 1005-1009.
21. Keren G, Belhassen B, Sherez J, Miller HI, Megidish R, Berenfeld D, et al. Apical hypertrophic cardiomyopathy: Evaluation by noninvasive and invasive technique in 23 patients. Circulation 1985; 71: 45-56.
22. Louie ER, Maron BJ. Apical hypertrophic cardiomyopathy: Clinical and two-dimensional echocardiographic assessment. Ann Intern Med 1987; 106: 663-670.
23. Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED. Apical hypertrophic cardiomyopathy: Clinical follow-up and diagnostic correlates. J Am Coll Cardiol 1990; 15: 83-90.
24. Chikamori T, Doi YL, Akizawa M, Yonezawa Y, Ozawa T, McKenna WJ. Comparison of clinical, morphological, and prognostic feature in hypertrophic cardiomyopathy between Japanese and Western patients. Clin Cardiol 1992; 15: 833-837.
25. Choi EY, Rim SJ, Ha JW, Kim YJ, Lee SC, Kang DH, et al. Phenotypic spectrum and clinical characteristics of apical hypertrophic cardiomyopathy: Multicenter echo-Doppler study. Cardiology 2008; 110: 53-61.
26. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001; 104: 2517-2524.
27. Doi Y, Kitaoka H. Hypertrophic cardiomyopathy in the elderly: Significance of atrial fibrillation. J Cardiol 2001; 37: 133-138.
28. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahishi M, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997; 16: 379-382.
29. Anan R, Shono H, Kisanuki A, Arima S, Nakao S, Tanaka H. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation 1998; 98: 391-397.
30. Mogensen J, Murphy RT, Kubo T, Bahl A, Moon JC, Klansen IC, et al. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 44: 2315-2325.
31. Olson TM, Doan TP, Kishimoto NY, Whitby FG, Ackerman MJ, Fananapazir L. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000; 32: 1687-1694.
32. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chanq A, Dalakas MC, et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1006; 13: 63-69.
33. Arad M, Penas-Lado M, Monserrat L, Maron BJ, Sherrid M, Ho CY, et al. Gene mutations in apical hypertrophic cardiomyopathy Circulation 2005; 112: 2805-2811.
34. Monserrat L, Hermida-Prieto M, Fernandez X, Rodriguez I, Dumont C, Cazon L, et al. Mutations in the alpha-cardiac gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J 2007; 28: 1953-1961.